Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica M Sparkenbaugh

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Research and Practice in Thrombosis and Haemostasis|August 5, 2024
Disease severity drives risk of venous thrombotic events in women with sickle cell disease in a single-center retrospective studyJennifer Light, Christina M Abrams, Anton Ilich, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 30, 2009
Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicityPatrick J Shaw, Kevin M Beggs, Erica M Sparkenbaugh, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2009
Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injuryWei Zou, Kevin M Beggs, Erica M Sparkenbaugh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2008
Gene expression profiles in livers from diclofenac-treated rats reveal intestinal bacteria-dependent and -independent pathways associated with liver injuryXiaomin Deng, Michael J Liguori, Erica M Sparkenbaugh, et al.
Blood Advances|February 3, 2026
Targeting PAR1 Biased Signaling with Parmodulin Reduces Thromboinflammation and Acute Lung Injury in Sickle Cell DiseaseNirupama Ramadas, Kailyn Lowder, Joshua Dutton, et al.
Blood|January 25, 2020
Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell diseaseErica M Sparkenbaugh, Chunsheng Chen, Tomasz Brzoska, et al.
Blood|January 23, 2014
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell diseaseErica M Sparkenbaugh, Pichika Chantrathammachart, Jacqueline Mickelson, et al.
Haematologica|January 18, 2015
Excess of heme induces tissue factor-dependent activation of coagulation in miceErica M Sparkenbaugh, Pichika Chantrathammachart, Shaobin Wang, et al.
ACS Central Science|July 30, 2020
Enzymatic Synthesis of Chondroitin Sulfate E to Attenuate Bacteria Lipopolysaccharide-Induced Organ DamageJine Li, Erica M Sparkenbaugh, Guowei Su, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2011
The role of hypoxia-inducible factor-1α in acetaminophen hepatotoxicityErica M Sparkenbaugh, Yogesh Saini, Krista K Greenwood, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Research and Practice in Thrombosis and Haemostasis|August 5, 2024
Disease severity drives risk of venous thrombotic events in women with sickle cell disease in a single-center retrospective studyJennifer Light, Christina M Abrams, Anton Ilich, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 30, 2009
Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicityPatrick J Shaw, Kevin M Beggs, Erica M Sparkenbaugh, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2009
Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injuryWei Zou, Kevin M Beggs, Erica M Sparkenbaugh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2008
Gene expression profiles in livers from diclofenac-treated rats reveal intestinal bacteria-dependent and -independent pathways associated with liver injuryXiaomin Deng, Michael J Liguori, Erica M Sparkenbaugh, et al.
Blood Advances|February 3, 2026
Targeting PAR1 Biased Signaling with Parmodulin Reduces Thromboinflammation and Acute Lung Injury in Sickle Cell DiseaseNirupama Ramadas, Kailyn Lowder, Joshua Dutton, et al.
Blood|January 25, 2020
Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell diseaseErica M Sparkenbaugh, Chunsheng Chen, Tomasz Brzoska, et al.
Blood|January 23, 2014
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell diseaseErica M Sparkenbaugh, Pichika Chantrathammachart, Jacqueline Mickelson, et al.
Haematologica|January 18, 2015
Excess of heme induces tissue factor-dependent activation of coagulation in miceErica M Sparkenbaugh, Pichika Chantrathammachart, Shaobin Wang, et al.
ACS Central Science|July 30, 2020
Enzymatic Synthesis of Chondroitin Sulfate E to Attenuate Bacteria Lipopolysaccharide-Induced Organ DamageJine Li, Erica M Sparkenbaugh, Guowei Su, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2011
The role of hypoxia-inducible factor-1α in acetaminophen hepatotoxicityErica M Sparkenbaugh, Yogesh Saini, Krista K Greenwood, et al.
Pageof 4